Viewing Protocol Section

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT06032546
Ignite Creation Date: 2024-05-06 @ 7:30 PM
Last Modification Date: 2024-10-26 @ 3:08 PM
Study NCT ID: NCT06032546
Protocol Section: NCT06032546
Start Identification Module Data
Expand Identification Module Data
Brief Title: A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus HIV Receiving Intravenous IV Infusion or Subcutaneous SC Injection of Budigalimab andor ABBV-382
Official Title: A Phase 2 Multicenter Randomized Double-Blind Placebo-controlled Study to Evaluate Efficacy Safety Tolerability and Pharmacokinetics of Budigalimab andor ABBV-382 in People Living With HIV on Stable Antiretroviral Therapy Undergoing Analytical Treatment Interruption
Acronym: None
Organization: AbbVie
Organization Class: INDUSTRY
Organization Study ID: M19-965
Secondary IDs
Secondary ID Type Domain Link
2023-505900-53-00 OTHER EU CT None
Start Status Module Data
Status Verified Date: 2024-10
Overall Status: RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: AbbVie
Lead Sponsor Class: INDUSTRY
Lead Sponsor: AbbVie
Start Oversight Module Data 461436
Description Module: 464936
Study Last Update Post Date Type(Status Module):
Attachment: Upload